Skip to main content

Table 2 Clinical parameters for the study groups

From: Tissue inhibitor of metalloproteinase 4 in aqueous humor of patients with primary open angle glaucoma, pseudoexfoliation syndrome and pseudoexfoliative glaucoma and its role in proteolysis imbalance

  Control POAG PXS PXG
(n = 44) (n = 36) (n = 44) (n = 44)
AGE(years) 75.27 ± 5.66 (63–86) 75.74 ± 7.4 (59–86) (p = 0.96) 75.76 ±5.15 (61–84) (p = 0.96) 75.96 ± 6.37 (64–88) (p = 0.96)
IOP (mm Hg) 14 ± 2.35 (9–17) 19 ±6.6 (10–40) 14.7 ± 3 (9–20) 21.1 ±9,3 (8–38)
Optic nerve c/d ratio 0.25 ± 0.053 (0.1–0.4) 0.62 ± 0.17 (0.4-0.9) 0.28 ±0.071 (0.2–0.4) 0.68 ± 0.16 (0.4–0.9)
Number of topical medications nil 1 (49%) nil 1 (9%)
  2 (23%)   2 (13%)
  3 (11%)   3 (47%)
  4 (6%)   4 (22%)
  1. POAG: Primary open angle glaucoma, PXS: Pseudoexfoliation, PXG: Pseudoexfoliation glaucoma, c/d: cup-to-disc ratio. Results are presented as mean ± SD (range).
  2. p values refer to the comparison between each study group versus controls with the Kolmogorov-Smirnoff test.